Questions on Hematopoietic and immunosuppressants Flashcards
The nurse is monitoring a client who is receiving epoetin alfa (Epogen, Procrit) for adverse effects of the medication. Which finding indicates an adverse effect?
- Diarrhea
- Depression
- Bradycardia
- Hypertension
- Hypertension
The nurse is evaluating the results of laboratory studies for a client receiving epoetin alfa (Epogen, Procrit). When should the nurse expect to note a therapeutic effect of this medication?
- Immediately
- 3 days after therapy
- 2 weeks after therapy
- After 1 week of therapy
- 2 weeks after therapy
The nurse is preparing to administer filgrastim (Neupogen) to a client with a diagnosis of agranulocytosis. The client asks the nurse about the purpose of the medication. The nurse explains that this medication will have which action?
- Prevent bleeding.
- Prolong the clotting time.
- Increase the red blood cell count.
- Promote the growth of neutrophils.
- Promote the growth of neutrophils
A home care nurse is preparing to administer filgrastim (Neupogen) to a client. The nurse plans to administer the medication by which route?
- Oral
- Subcutaneous
- Intramuscular
- Intravenous bolus
- Subcutaneous
The nurse is reviewing the laboratory test results for a client who is receiving filgrastim (Neupogen). Which reported value would indicate an effective response to this medication?
- Hematocrit of 42%
- Blood glucose level of 120 mg/dL
- Platelet count of 150,000 cells/mm3
- Neutrophil count of 10,000 cells/mm3
- Neutrophil count of 10,000 cells/mm3
The nurse is preparing to administer filgrastim (Neupogen) by intravenous (IV) infusion. Which nursing action is appropriate for administering this medication?
- Shake the solution before drawing it up.
- Dilute the medication in normal (0.9%) saline.
- Discard the medication if it has been refrigerated.
- Dilute the medication in 5% dextrose in water (D5W).
- Dilute the medication in 5% dextrose in water (D5W).
A client with chronic kidney disease was started on epoetin alfa (Epogen, Procrit) 2 months earlier. In evaluating the therapeutic effectiveness of the medication, the nurse should expect the client to exhibit which finding?
- A decrease in blood pressure
- An increase in white blood cells
- An increase in serum hematocrit
- A decrease in serum creatinine levels
- An increase in serum hematocrit
Epoetin alfa (Epogen, Procrit) has been prescribed for a client with chronic kidney disease who is being cared for by a nursing student. The nursing instructor determines that the student understands the procedure for administering the medication when the student states that which route of administration is acceptable?
- Oral
- Z-track
- Intramuscular
- Subcutaneous
- Subcutaneous
Epoetin alfa (Epogen, Procrit) by the subcutaneous route is prescribed for a client. Which is the correct action for the nurse to implement?
- Shake the vial before use.
- Freeze the medication before use.
- Refrigerate the medication until used.
- Obtain syringes with 1½-inch needles from the pharmacy
- Refrigerate the medication until used.
The client in chronic kidney disease is receiving epoetin alfa (Epogen). The nurse should monitor this client for which adverse effect of this medication?
- Fever
- Depression
- Bradycardia
- Hypertension
- Hypertension
The nurse is caring for a patient with anemia related to chronic renal failure. Which agent below might be used to treat the anemia?
A. Filgrastim (Neupogen)
B. Sargramostim (Leukine)
C. Oprelvekin (Neumega)
D. Epoetin alfa (Procrit)
D. Epoetin alfa (Procrit)
The nurse is administering epoetin alfa (Procrit) to a patient receiving chemotherapy. Which adverse effect below is a potential risk with this drug?
A. Accelerated tumor progression
B. Hypotension
C. Easy bruising
D. Bone pain
A. Accelerated tumor progression
The nurse is caring for a patient undergoing cancer chemotherapy who presents with rash, bone pain, hypertension, and pedal edema. Which symptom is most likely an adverse reaction to the filgrastim (Neupogen) he is receiving?
A. Rash
B. Bone pain
C. Hypertension
D. Pedal edema
B. Bone pain
The nurse is evaluating the effectiveness of the drug oprelvekin (Neumega) in a patient undergoing cancer chemotherapy. Which finding below is the most indicative that this drug is having its intended effect?
A. Platelet count = 150 × 103/mm3 B. Hemoglobin = 13.2 g/dL C. White blood cells = 5500/mm3 D. Total lymphocyte count = 1000/mm3
A. Platelet count = 150 × 103/mm3
A transplant recipient patient is receiving cyclosporine (Sandimmune). Which of these responses should a nurse expect if the medication is having the desired effect?
A. Increased antibody response
B. Increased natural killer (NK) cellular activity
C. Suppression of T lymphocytes
D. Suppression of hepatic metabolism of steroids
C. Suppression of T lymphocytes